BTG acquires Novate Medical for up to $150 million

British healthcare company BTG Plc acquired U.S. medical device maker Novate Medical for $20 million upfront and up to $130 million in milestone payments. Novate developed the Sentry vascular device for preventing pulmonary embolism.

“BTG has paid $20 million in cash to buy Novate, and may pay a further $130 million depending on the device hitting certain sales-related milestones”sg.finance.yahoo.com

• 2 sources
• sg.finance.yahoo.comBritish healthcare firm BTG buys U.S. vascular device makerReutersSep 7, 2018
• serobavc.comNovate Acquired By BTG for Up To $150m – Seroba LifesciencesEditeurSep 7, 2018

Summarized from public sources; check the original articles before acting on it.